Drawing for CADMUTEX

USPTO serial 75519465

CADMUTEX

Reviewed by CopyMark Law Group

Reg. 2576957Status 710
Filing date
Status date
Registration date
Jun 11, 2002
Examiner
MANDIR, FREDERICK
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CADMUTEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CHARLES L GAGNEBIN III

CHARLES L GAGNEBIN III WEINGARTEN SCHURGIN GAGNEBIN & HAYES10 POST OFFICE SQBOSTON, MA 02109UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005antibodies for use in diagnostics and therapy, namely monoclonal antibodies for determining the level of mutant E-cadherin peptide in body fluids and for cancer therapySECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 14, 2009C8..CANCELLED SEC. 8 (6-YR)—
Sep 20, 2007CFITCASE FILE IN TICRS—
Jun 11, 2002R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 19, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2002NPUBNOTICE OF PUBLICATION—
Dec 12, 20011.BDSec. 1(B) CLAIM DELETED—
Sep 20, 2001PCGRPETITION TO DIRECTOR GRANTED—
Sep 13, 2001REINREINSTATED—
Jul 30, 2001PCRCPETITION TO DIRECTOR RECEIVED—
May 30, 2001ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 3, 2001IUCNNOTICE OF ALLOWANCE CANCELLED—
Sep 13, 2000EX2GSOU EXTENSION 2 GRANTED—
Jul 13, 2000EXT2SOU EXTENSION 2 FILED—
Mar 31, 2000EX1GSOU EXTENSION 1 GRANTED—
Feb 1, 2000EXT1SOU EXTENSION 1 FILED—
Aug 3, 1999NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 11, 1999PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 9, 1999NPUBNOTICE OF PUBLICATION—
Mar 1, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 25, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance